NOMURA: Japan REIT sector - Ongoing property sales by REITs

FULL REPORT

Property sales constitute viable option even if pros and cons are not immediately apparent

On 31 August Sekisui House SI Residential Investment [8973] (Buy) announced the sale of b-town Minamiaoyama, an urban retail facility. It has been selling off commercial facilities since June 2014 in order to turn itself into a specialist residential REIT, and to date had sold six properties. It had hitherto decided not to sell b-town Minamiaoyama because it was carrying unrealized losses, with appraisal value of ¥1.17bn at end-16/3 versus book value of ¥1.49bn. However, it has now managed to sell it to a third party based in Japan that made an offer of ¥1.56bn, well above the property's appraisal value and also higher than its book value. Sekisui House SI Residential Investment said that it received an offer for the property in excess of its book value because the real estate market has been buoyant recently.

 

DNB NEWS & RESEARCH for 8/29..UK CLOSED BANK HOLIDAY EUROPE VOLS -60%

SKANSKA:     U/G from HOLD(BUY), UP PT from SEK185(220) improved USA outlook
LUNDIN PET:  REIT BUY,  UP PT from SEK155(162) Positive Johan Sverdrup news
DETNOR:      REIT BUY,  UP PT from NOK125(128) better production level,lower cap
STATOIL:     REIT BUY,  PT NOK160support update on development costs in Norway
AURORA LPG:  REIT HOLD,CUT PT NOK22.50(11)
AF GRUPPEN:  REIT SELL, UP PT from SEK90(100) concern remains premium valuation

Janney/IRET: Initiating coverage of IRET with a Buy rating

FULL REPORT

Investors Real Estate Trust

IRET - BUY

Price - $6.46 | Fair Value Estimate - $7.00

Initiating coverage of IRET with a Buy rating

We are initiating coverage of IRET with a Buy rating. Our $7 estimate of fair value implies ~10% upside for the stock, which when combined with an 8.1% dividend yield, provides an attractive potential return in the current market environment.

  • Transitioning into a pure-play apartment REIT. Based in Minot, ND, IRET owned a portfolio of 102 apartment assets totaling 12,974 units across 7 states in the upper Midwest (as well as healthcare, office and industrial assets slated to be sold) as of April 30, with over one-third of its NOI coming from North Dakota. As of F4Q16, IRET’s apartment portfolio was 90.8% occupied with an average monthly rent of $960 (both among the lowest in the apartment REIT subsector).

  • De-leveraging via asset sales, inexpensive valuation, and strong returns from redevelopment the reasons to own IRET. We see upside to IRET’s stock price given (1) management has targeted ~$600M of non-core assets for dispositions and will use a portion of the proceeds to reduce debt, (2) a reasonable valuation from both an NAV and multiple perspective (plus an 8.1% current dividend yield), and (3) strong returns (11.3% thus far) on its kitchen and bathroom redevelopment program being rolled out across its portfolio.

  • 8.1% dividend yield as well as NAV and multiple valuations are attractive. IRET is trading at a 7.4% implied capitalization rate (7.2% or $81,000 per unit for their apartment assets), and C2017 FFO and AFFO multiples of 13.3x and 15.1x, respectively. Our $7 fair value estimate is based on our DCF valuation model.

  • Exposure to “unloved markets”, lengthy transition to an apartment REIT, and the North Dakota market overhang are our biggest concerns. However, the IRET story is not without risks, most notably: (1) IRET’s core upper Midwest markets are largely “unloved” by investors; (2) the transition to a pure-play apartment REIT could take several years and become messy (including a potential “right-sizing” of the dividend); and (3) we believe IRET’s ND markets (~35% of NOI) are likely to remain operationally challenging and an overhang on the stock.

  • We remain Neutral on the US REITs despite the group having already exceeded our 10% total return expectation for 2016. Heading into 2H16, we believe strong generalist investor interest, solid internal growth, and continued access to inexpensive and plentiful capital are somewhat offset by strong valuations, greater levels of new supply, and the threat of higher interest rates

NOMORA JAPAN - Unizo Holdings (3258 JP) (Neutral) Factoring in dilution from capital increase

Aggressive investment in Washington, DC

REPORT

We have lowered our target price by 35% and retain our Neutral rating. The cut in the target price reflects the 20% increase in shares out resulting from the capital increase staged in July, as well as an increase in the cap rate we use to calculate NAV from 4.5% to 5.0%. This revision of the cap rate reflects increased uncertainty on financial and capital markets, for example from Brexit, a slowdown in office rent rises, and a slowdown in the pace of growth in hotel room rates on deteriorating corporate demand, although inbound demand is buoyant. We estimate that 80% of 17/3 NOI will come from office buildings and 20% from hotels, and we apply a cap rate of 5.0% to both property types. The revision to our cap rate is on the large side not only because of the difficulty in hiking rents on office buildings in Japan but also because of the company’s decision to spend a total of ¥50bn on purchasing three buildings in Washington, DC from July onwards, including 1100 First Street NE, which will likely result in US assets accounting for more than 30% of total property, plant & equipment as at end-17/3, and cap rates on US real estate are higher than on office buildings in the five central wards of Tokyo.

Robert Stevenson Update: Community Healthcare Trust Inc (CHCT) - BUY 2Q16 Earnings REITView: Solid results; raising FV to $24

FULL REPORT

Flash Takeaways:

CHCT reported 2Q16 FFOPS of $0.32 (Normalized was $0.34). We were at $0.31 per share, while consensus was at $0.32 per share. The 3 acquisitions ($33.5M) in 2Q16 and the 4 in the pipeline ($13.4M) are the main takeaways.

Analysts Notes:

  • Occupancy 93.0% at June 30. At the end of 2Q16, CHCT had investments in 48 properties and mortgages across 18 states, totaling roughly 1.1 million square feet, that were 93% occupied. We note that leases representing 7.2% of CHCT’s annualized rent will expire in 2H16, with roughly 12.2% expiring in 2017.

  • CHCT acquires 3 properties in 2Q16 for $33.5M. The 3 properties were 93.7% leased overall and total 153K square feet. CHCT had previously announced the acquisition of a 13,835 square foot surgery center in Arizona for $3.1M (100% leased) and the 85,000 square foot behavioral hospital in Des Plaines, IL for $20M (100% leased), for which CHCT had previously extended a $12.5M mortgage loan and subsequently exercised their purchase option. In addition to the two previously announced acquisitions, CHCT closed on a 54,611 square foot MOB in Independence, Ohio for $10.4M (82.3% leased).

  • Credit facility increased by $75M; dividend increased by $0.0025. On 8/10/16, CHCT increased the size of their credit facility from $75 million to $150 million, while also reducing their interest rate by 25bps. Additionally, the quarterly dividend increased by $0.0025 from $0.3775 to $0.3800.

  • Pipeline currently 4 properties totaling nearly $13.4M. CHCT has purchase agreements on four properties for a total cost of $13.4M. CHCT estimates an expected return on these properties in the range of 9.16%-9.97%.

  • Increasing 2016 FFOPS estimates. Given 2Q16 results, we are increasing our 2016 FFOPS estimate from $1.37 to $1.39 and our 2017 estimates from $1.53 to $1.57. Consensus is at $1.46 and $1.66, respectively. We are maintaining our Buy rating and are increasing our Fair Value estimate from $23 to $24.

Daiwa House Industry (1925 JP) (Buy) 17/3 Q1 results

Sale of logistics facilities to private REIT in Q1

Daiwa House Industry released 17/3 Q1 results on 9 August. We had thought that its results might be hit by the disappearance of substantial gains on the sale of logistics and commercial facilities in 16/3 Q1 (¥24.5bn at the gross profit level), but in the event operating profits rose 4% y-y (and included gains on property sales of ¥12.9bn). This mainly reflected the housing business, where sales rose 13% and the gross margin improved from 19.4% to 20.5%. However, we had already expected this gross margin to improve in 17/3. Although progress with construction projects has been rapid, the amount of work at hand has not prompted us to change our outlook for housing operations in 17/3, or indeed our earnings forecasts. We retain our target price and reiterate our Buy rating amid favorable conditions.

REPORT